normal plasma cell controls Search Results


96
Vector Laboratories pdx 1 antibody
Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on <t>PDX-1</t> and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.
Pdx 1 Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pmc02731539-38-32-40?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
pdx 1 antibody - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Miltenyi Biotec primary human normal cd138þ plasma cells npcs
Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on <t>PDX-1</t> and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.
Primary Human Normal Cd138þ Plasma Cells Npcs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pm35369902-57-22-32?v=Miltenyi+Biotec
Average 96 stars, based on 1 article reviews
primary human normal cd138þ plasma cells npcs - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Vector Laboratories blocking permeablising solution
Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on <t>PDX-1</t> and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.
Blocking Permeablising Solution, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pmc02902986-56-8-15?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
blocking permeablising solution - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

94
Vector Laboratories serum normal orse serum for tryptase and rabbit serum for chymase ectastain elite kit vector laboratories burlingame cal fornia
Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on <t>PDX-1</t> and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.
Serum Normal Orse Serum For Tryptase And Rabbit Serum For Chymase Ectastain Elite Kit Vector Laboratories Burlingame Cal Fornia, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pm15519020-65-10-24?v=Vector+Laboratories
Average 94 stars, based on 1 article reviews
serum normal orse serum for tryptase and rabbit serum for chymase ectastain elite kit vector laboratories burlingame cal fornia - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Thermo Fisher cell lines in trizol
Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on <t>PDX-1</t> and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.
Cell Lines In Trizol, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pmc03973192-142-13-17?v=Thermo+Fisher
Average 96 stars, based on 1 article reviews
cell lines in trizol - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
Promega psv β-galactosidase control vector
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Psv β Galactosidase Control Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pmc02972275-469-11-15?v=Promega
Average 90 stars, based on 1 article reviews
psv β-galactosidase control vector - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Promega prl vector
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Prl Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/10__1074_slash_jbc__m208905200-157-10-12?v=Promega
Average 90 stars, based on 1 article reviews
prl vector - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
ATCC normal plasma cells
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Normal Plasma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pm30272368-30-9-20?v=ATCC
Average 99 stars, based on 1 article reviews
normal plasma cells - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

95
Vector Laboratories animal free blocker jo urn al pr e p r o f mir 146a 5p regulates β cell mitochondrial health 13
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Animal Free Blocker Jo Urn Al Pr E P R O F Mir 146a 5p Regulates β Cell Mitochondrial Health 13, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pm39342996-356-5-24?v=Vector+Laboratories
Average 95 stars, based on 1 article reviews
animal free blocker jo urn al pr e p r o f mir 146a 5p regulates β cell mitochondrial health 13 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

96
Vector Laboratories sp 2001 normal rabbit serum vector s 5000 20 tissue tek oct compound sakura 4583 triton x 100 sigma adlrich 1003287133
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Sp 2001 Normal Rabbit Serum Vector S 5000 20 Tissue Tek Oct Compound Sakura 4583 Triton X 100 Sigma Adlrich 1003287133, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pm41865375-227-194-198?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
sp 2001 normal rabbit serum vector s 5000 20 tissue tek oct compound sakura 4583 triton x 100 sigma adlrich 1003287133 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

99
ATCC u87 cells
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
U87 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/us08506963-203-15-25?v=ATCC
Average 99 stars, based on 1 article reviews
u87 cells - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

96
Vector Laboratories horse serum albumin for e cadherin
JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to <t>co-expressed</t> <t>β-gal.</t> Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.
Horse Serum Albumin For E Cadherin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+plasma+cell+controls/pmc05529910-63-17-26?v=Vector+Laboratories
Average 96 stars, based on 1 article reviews
horse serum albumin for e cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on PDX-1 and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.

Journal: Diabetes

Article Title: Involvement of Per-Arnt-Sim Kinase and Extracellular-Regulated Kinases-1/2 in Palmitate Inhibition of Insulin Gene Expression in Pancreatic β-Cells

doi: 10.2337/db08-0579

Figure Lengend Snippet: Inhibition of ERK1/2 does not prevent palmitate inhibition of MafA expression and has no effect on PDX-1 and C/EBPβ expression. MIN6 cells were cultured for 24 h with 2 mmol/l or 11 mmol/l glucose, ± 0.5 mmol/l palmitate, in the presence or absence of U0126 (30 μmol/l). MafA ( A ), PDX-1 ( B ), and C/EBPβ ( C ) mRNA levels were measured by RT-PCR and normalized to β-actin mRNA. Results are expressed as fold increase of the ratio of gene/β-actin mRNA over control value and are means ± SE of three replicate experiments. ** P < 0.01, *** P < 0.001 vs. vehicle. Vehicle, □; U0126, ■.

Article Snippet: For immunohistochemistry, MIN6 cells were fixed with 3.7% formaldehyde for 30 min and permeabilized in cold methanol for 20 min. After saturation with 5% normal horse serum, cells were incubated with rabbit anti–PDX-1 antibody, followed by fluorescein isothiocyanate goat anti-rabbit (Vector, Burlingame, CA).

Techniques: Inhibition, Expressing, Cell Culture, Reverse Transcription Polymerase Chain Reaction

Overexpression of PAS kinase prevents the inhibitory effects of palmitate on insulin gene expression. A : Representative hPASK and p85 immunoblots of control, Adv-Luc-infected, or Adv-hPASK wild-type infected MIN6 cells cultured for 24 h in 2 or 11 mmol/l glucose ± 0.5 mmol/l palmitate. B : Insulin pre-mRNA levels. Results are expressed as fold increase of the ratio of mPre-INS2/β-actin mRNA over control value and are mean ± SE of seven replicate experiments. * P < 0.05, ** P < 0.01. C : Representative hPASK and p85 immunoblots of control, Adv-Luc-infected, Adv-hPASK wild-type or Adv-hPASK kinase-dead infected rat islets cultured for 24 h in the presence of 16.7 mmol/l glucose + 0.5 mmol/l palmitate. D : Pre-INS2, MafA, PDX-1, and C/EBPβ mRNA levels were measured by RT-PCR and normalized to cyclophillin mRNA. Results are expressed as fold increase of the ratio of rGene/rCyclophillin mRNA over control value (Adv-Luc) and are means ± SE of three replicate experiments. * P < 0.05; ** P < 0.01; *** P < 0.001. Cont, control; KD, kinase dead; Luc, luciferase; WT, wild type.

Journal: Diabetes

Article Title: Involvement of Per-Arnt-Sim Kinase and Extracellular-Regulated Kinases-1/2 in Palmitate Inhibition of Insulin Gene Expression in Pancreatic β-Cells

doi: 10.2337/db08-0579

Figure Lengend Snippet: Overexpression of PAS kinase prevents the inhibitory effects of palmitate on insulin gene expression. A : Representative hPASK and p85 immunoblots of control, Adv-Luc-infected, or Adv-hPASK wild-type infected MIN6 cells cultured for 24 h in 2 or 11 mmol/l glucose ± 0.5 mmol/l palmitate. B : Insulin pre-mRNA levels. Results are expressed as fold increase of the ratio of mPre-INS2/β-actin mRNA over control value and are mean ± SE of seven replicate experiments. * P < 0.05, ** P < 0.01. C : Representative hPASK and p85 immunoblots of control, Adv-Luc-infected, Adv-hPASK wild-type or Adv-hPASK kinase-dead infected rat islets cultured for 24 h in the presence of 16.7 mmol/l glucose + 0.5 mmol/l palmitate. D : Pre-INS2, MafA, PDX-1, and C/EBPβ mRNA levels were measured by RT-PCR and normalized to cyclophillin mRNA. Results are expressed as fold increase of the ratio of rGene/rCyclophillin mRNA over control value (Adv-Luc) and are means ± SE of three replicate experiments. * P < 0.05; ** P < 0.01; *** P < 0.001. Cont, control; KD, kinase dead; Luc, luciferase; WT, wild type.

Article Snippet: For immunohistochemistry, MIN6 cells were fixed with 3.7% formaldehyde for 30 min and permeabilized in cold methanol for 20 min. After saturation with 5% normal horse serum, cells were incubated with rabbit anti–PDX-1 antibody, followed by fluorescein isothiocyanate goat anti-rabbit (Vector, Burlingame, CA).

Techniques: Over Expression, Expressing, Western Blot, Infection, Cell Culture, Reverse Transcription Polymerase Chain Reaction, Luciferase

PDX-1 protein expression in MIN6 cells overexpressing hPASK wild-type or kinase-dead. MIN6 cells were infected with adenoviruses expressing Luc ( A-C ), wild-type hPASK ( D-F ), or kinase-dead hPASK ( G-I ), and cultured for 24 h with 2 mmol/l glucose ( A , D , and G ), 11 mmol/l glucose ( B , E , and H ), or 11 mmol/l glucose + palmitate ( C , F , and I ). Cells were immunostained for PDX-1 and examined under a fluorescence microscope. Images are representative of three replicate experiments. KD, kinase dead; Luc, luciferase; WT, wild type. (A high-quality digital representation of this figure is available in the online issue.)

Journal: Diabetes

Article Title: Involvement of Per-Arnt-Sim Kinase and Extracellular-Regulated Kinases-1/2 in Palmitate Inhibition of Insulin Gene Expression in Pancreatic β-Cells

doi: 10.2337/db08-0579

Figure Lengend Snippet: PDX-1 protein expression in MIN6 cells overexpressing hPASK wild-type or kinase-dead. MIN6 cells were infected with adenoviruses expressing Luc ( A-C ), wild-type hPASK ( D-F ), or kinase-dead hPASK ( G-I ), and cultured for 24 h with 2 mmol/l glucose ( A , D , and G ), 11 mmol/l glucose ( B , E , and H ), or 11 mmol/l glucose + palmitate ( C , F , and I ). Cells were immunostained for PDX-1 and examined under a fluorescence microscope. Images are representative of three replicate experiments. KD, kinase dead; Luc, luciferase; WT, wild type. (A high-quality digital representation of this figure is available in the online issue.)

Article Snippet: For immunohistochemistry, MIN6 cells were fixed with 3.7% formaldehyde for 30 min and permeabilized in cold methanol for 20 min. After saturation with 5% normal horse serum, cells were incubated with rabbit anti–PDX-1 antibody, followed by fluorescein isothiocyanate goat anti-rabbit (Vector, Burlingame, CA).

Techniques: Expressing, Infection, Cell Culture, Fluorescence, Microscopy, Luciferase

JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to co-expressed β-gal. Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.

Journal: Journal of Cell Science

Article Title: The AP-1 family member FOS blocks transcriptional activity of the nuclear receptor steroidogenic factor 1

doi: 10.1242/jcs.055806

Figure Lengend Snippet: JUN and FOS proteins are recruited to the CYP17 promoter and repress its transcription. (A,B) H295R cells were untreated (basal) or incubated for 1 hour with Ang II (100 nM) or TPA (10 nM) alone or in the presence of PD98059 (10 μM). In vivo binding of JUN and FOS to the CYP17 promoter was examined using ChIP assay. Immunoprecipitated (JUN, FOS) and total (10% input) DNA were subject to real time RT-PCR using specific primers. Ct values from immunoprecipitated samples were normalized to the input Ct values (*P<0.001 compared with basal and **P<0.001 compared with TPA). (C) H295R cells were transfected with a CYP17 promoter construct (1 μg) and 0.1 μg of expression vector for JUN and FOS. (D) H295R cells were co-transfected with 1 μg of a luciferase promoter construct containing 381 bp of the CYP17 promoter, increasing doses of FOS (0.3, 1, 3, 10, 30, 100 ng), SF-1 (0.3 μg) and JUN (0.1 μg) expression plasmids. (E,F) H295R cells were co-transfected with 1 μg of CYP17 reporter construct mutated at the SF-1 sites (CYP17 SF-1/3mut; E) or of CYP17 AP1 −164 mut (F) together with SF-1 (0.3 μg), JUN (0.1 μg) and FOS (0.1 μg). (G) Cells were transfected with CYP17 reporter construct (WT) or a construct containing 381 bp of the promoter region mutated at an AP-1 site (CYP17 AP1 −164 mut). (H) Cells were transfected with the CYP17 reporter and increasing doses of JUN. Data were normalized to co-expressed β-gal. Results represent the mean + s.e.m. of data from two to three independent experiments, each performed in triplicate. *P<0.001 compared with SF-1; ^P<0.001 compared with basal (without expression vectors) mut CYP17; **P<0.05 compared with CYP17 WT; +P<0.001 compared with basal (without expression vectors) WT CYP17.

Article Snippet: To normalize luciferase activity, cells were co-transfected with 50 ng of pSV β-galactosidase control vector (Promega).

Techniques: Incubation, In Vivo, Binding Assay, Immunoprecipitation, Quantitative RT-PCR, Transfection, Construct, Expressing, Plasmid Preparation, Luciferase